Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Tolerance in HLA-Matched Living Donor Kidney Transplantation
NCT00319657Phase 2Active, not recruiting
- Sponsor
- Stanford University
- Start
- Jul 2004
- Primary completion
- Jul 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in kidney transplantation, sponsored by Stanford University. Started Jul 2004; status: active, not recruiting.
02
Drugs
leuprolide
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00319657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319657.